Centessa Pharmaceuticals plc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| MEDICXI VENTURES MANAGEMENT (JERSEY) LTD | 01/23/2026 | 19.96 M | $499.28 M | 0.00% | 14.88% |
| AVORO CAPITAL ADVISORS LLC | 03/16/2026 | 14.56 M | $364.03 M | 34.67% | 10.85% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 02/17/2026 | 11.28 M | $282.16 M | 12.42% | 8.41% |
| INDEX VENTURE LIFE ASSOCIATES VI LTD | 02/13/2026 | 9.96 M | $249.14 M | 0.00% | 7.43% |
| FMR LLC | 02/17/2026 | 8.96 M | $224.14 M | 42.77% | 6.68% |
| GENERAL ATLANTIC, L.P. | 02/17/2026 | 6.12 M | $153.00 M | -36.81% | 4.56% |
| FARALLON CAPITAL MANAGEMENT LLC | 02/17/2026 | 5.38 M | $134.48 M | 24.14% | 4.01% |
| TCG CROSSOVER MANAGEMENT, LLC | 02/17/2026 | 4.29 M | $107.20 M | 36.67% | 3.20% |
| JANUS HENDERSON GROUP PLC | 02/17/2026 | 4.09 M | $102.39 M | -24.31% | 3.05% |
| SIREN, L.L.C. | 02/13/2026 | 4.03 M | $100.73 M | 24.79% | 3.00% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 02/17/2026 | 3.93 M | $98.22 M | -18.25% | 2.93% |
| ECOR1 CAPITAL, LLC | 02/17/2026 | 3.12 M | $77.91 M | 466.36% | 2.32% |
| PERCEPTIVE ADVISORS LLC | 02/17/2026 | 2.92 M | $72.97 M | -5.91% | 2.17% |
| FRANKLIN RESOURCES INC | 02/11/2026 | 2.37 M | $59.23 M | -7.43% | 1.77% |
| FEDERATED HERMES, INC. | 02/12/2026 | 2.34 M | $58.58 M | 33.86% | 1.75% |
| FIRST LIGHT ASSET MANAGEMENT, LLC | 02/17/2026 | 2.28 M | $57.00 M | -37.32% | 1.70% |
| BRAIDWELL LP | 02/17/2026 | 2.19 M | $54.73 M | 100.00% | 1.63% |
| DEEP TRACK CAPITAL, LP | 02/13/2026 | 2.00 M | $50.02 M | 100.00% | 1.49% |
| MILLENNIUM MANAGEMENT LLC | 02/17/2026 | 1.87 M | $46.79 M | 107.33% | 1.39% |
| RTW INVESTMENTS, LP | 02/17/2026 | 1.79 M | $44.79 M | -21.86% | 1.33% |
| MAVERICK CAPITAL LTD | 02/13/2026 | 1.64 M | $41.11 M | 100.00% | 1.23% |
| FORESITE CAPITAL MANAGEMENT VI LLC | 02/17/2026 | 1.36 M | $34.11 M | 3.81% | 1.02% |
| CORMORANT ASSET MANAGEMENT, LP | 02/17/2026 | 1.33 M | $33.14 M | -31.17% | 0.99% |
| CAPITAL WORLD INVESTORS | 02/11/2026 | 1.16 M | $28.98 M | 69.20% | 0.86% |
| STEMPOINT CAPITAL LP | 02/17/2026 | 1.15 M | $28.86 M | 76.10% | 0.86% |
| AMERICAN CENTURY COMPANIES INC | 02/13/2026 | 1.13 M | $28.26 M | 3.01% | 0.84% |
| MORGAN STANLEY | 02/13/2026 | 1.11 M | $27.74 M | -1.36% | 0.83% |
| SOFINNOVA INVESTMENTS, INC. | 02/13/2026 | 1.10 M | $27.62 M | 100.00% | 0.82% |
| COMMODORE CAPITAL LP | 02/17/2026 | 1.00 M | $25.01 M | -64.91% | 0.75% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 949.54 K | $23.75 M | 71.71% | 0.71% |
| JAIN GLOBAL LLC | 02/17/2026 | 915.80 K | $22.90 M | 278.47% | 0.68% |
| D. E. SHAW & CO., INC. | 02/17/2026 | 831.64 K | $20.80 M | 1,191.58% | 0.62% |
| GOLDMAN SACHS GROUP INC | 03/25/2026 | 779.00 K | $19.48 M | 214.68% | 0.58% |
| OCTAGON CAPITAL ADVISORS LP | 02/17/2026 | 750.00 K | $18.76 M | -9.64% | 0.56% |
| BAKER BROS. ADVISORS LP | 02/17/2026 | 670.75 K | $16.78 M | 100.00% | 0.50% |
| AFFINITY ASSET ADVISORS, LLC | 02/13/2026 | 600.55 K | $15.02 M | -45.76% | 0.45% |
| BLACKROCK, INC. | 02/12/2026 | 592.60 K | $14.82 M | 45.11% | 0.44% |
| PFM HEALTH SCIENCES, LP | 02/17/2026 | 591.60 K | $14.80 M | -11.20% | 0.44% |
| 5AM VENTURE MANAGEMENT, LLC | 02/17/2026 | 580.95 K | $14.53 M | -14.69% | 0.43% |
| WOODLINE PARTNERS LP | 02/17/2026 | 578.25 K | $14.46 M | 437.05% | 0.43% |
| UBS GROUP AG | 01/29/2026 | 537.52 K | $13.44 M | 531.05% | 0.40% |
| CITADEL ADVISORS LLC | 02/17/2026 | 519.96 K | $13.00 M | 278.98% | 0.39% |
| ARMISTICE CAPITAL, LLC | 02/17/2026 | 500.00 K | $12.51 M | 32.28% | 0.37% |
| JANE STREET GROUP, LLC | 02/12/2026 | 480.20 K | $12.01 M | 1,893.29% | 0.36% |
| BALYASNY ASSET MANAGEMENT L.P. | 02/17/2026 | 468.82 K | $11.73 M | -41.81% | 0.35% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 02/12/2026 | 458.20 K | $11.46 M | 224.42% | 0.34% |
| WALLEYE CAPITAL LLC | 02/13/2026 | 441.16 K | $11.03 M | 100.00% | 0.33% |
| CANDRIAM S.C.A. | 04/30/2026 | 395.62 K | $9.89 M | 15.27% | 0.29% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 02/17/2026 | 378.74 K | $9.47 M | 100.00% | 0.28% |
| TD ASSET MANAGEMENT INC | 02/10/2026 | 376.34 K | $9.41 M | -19.41% | 0.28% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Centessa Pharmaceuticals plc institutional Ownership - FAQ's
During the previous two years, 186 institutional investors and hedge funds held shares of Centessa Pharmaceuticals plc. The most heavily invested institutionals were:
Medicxi Ventures Management (Jersey) Ltd: 19.96 M
FEDERATED HERMES, INC.: 2.05 M
ALPINE ASSOCIATES MANAGEMENT INC.: 865,500
UBS Group AG: 359,939
ROYCE & ASSOCIATES LP: 278,064
TD ASSET MANAGEMENT INC: 242,044
107.15% of Centessa Pharmaceuticals plc stock is owned by institutional investors.
Institutional investors have bought a total of 147.23 M shares in the last 24 months. This purchase volume represents approximately $3.84 B in transactions.